title: Zoledronic acid-associated thrombotic thrombocytopenic purpura.
authors.forename: G
authors.initials: G
authors.lastname: Ferretti
authors.forename: M C
authors.initials: MC
authors.lastname: Petti
authors.forename: P
authors.initials: P
authors.lastname: Carlini
authors.forename: M
authors.initials: M
authors.lastname: Zeuli
authors.forename: A
authors.initials: A
authors.lastname: Picardi
authors.forename: G
authors.initials: G
authors.lastname: Meloni
authors.forename: E
authors.initials: E
authors.lastname: Bria
authors.forename: P
authors.initials: P
authors.lastname: Papaldo
authors.forename: A
authors.initials: A
authors.lastname: Fabi
authors.forename: F
authors.initials: F
authors.lastname: Cognetti
mesh_terms: D001943:Breast Neoplasms / Q000188:drug therapy / Q000473:pathology; D004164:Diphosphonates / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006463:Hemolytic-Uremic Syndrome / Q000139:chemically induced*; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D011696:Purpura, Thrombocytopenic / Q000139:chemically induced*; D000077211:Zoledronic Acid
chemical_list: D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid